Format

Send to

Choose Destination
Drugs Context. 2015 May 1;4:212280. doi: 10.7573/dic.212280. eCollection 2015.

Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland.

Author information

1
Royal College of General Practitioners Immunisation Lead, President British Global & Travel Health Association and General Practitioner, Bracknell, UK;
2
Professional Officer, School & Public Health Nurses Association (SAPHNA), Aberford, UK;
3
Health Protection Scotland, Glasgow, Scotland;
4
Global Medical Affairs, AstraZeneca, London, UK.

Abstract

In 2012, the Joint Committee on Vaccination and Immunisation recommended that the National Immunisation Programme for influenza be extended to include healthy children/adolescents aged 2-17 years. In the UK, extension of this new immunisation programme began in 2013-2014 and targeted children aged 2 years and 3 years in primary care. Several implementation pilots were undertaken in primary schools across England, Scotland, Wales and Northern Ireland, as well as a single pilot in a secondary school in England. This article shares lessons learnt from experiences in England and Scotland to provide guidance for other countries considering the addition of childhood influenza vaccination into their national immunisation programmes. Recommendations are provided to help ensure effective preparation and management of new childhood influenza vaccination programmes in other countries. This article describes the processes utilised in England and Scotland for programme setup, workforce management, identification and care of contraindicated patients, collection of data on vaccine uptake, communication strategies, and education of parents and children.

KEYWORDS:

England; Scotland; children; influenza; pilot project; schools; vaccination; vaccine

Supplemental Content

Full text links

Icon for Just Medical Media Limited Icon for PubMed Central
Loading ...
Support Center